{"entity":{"id":"idea-fund-metastasis-moonshot","kind":"idea","name":"A ring-fenced metastasis programme with metastasis-specific endpoints","aka":[],"tldr":"Metastasis causes about nine in ten cancer deaths but gets a small slice of research money. This would ring-fence a tenth of national cancer research budgets for the biology and trials of spread itself.","summary":"A dedicated, multi-year programme funds metastasis biology (dissemination, dormancy, organ-specific colonisation), metastasis-directed therapies and, crucially, trials whose primary endpoint is the prevention or delay of new metastases rather than shrinkage of existing ones. It would include model-building (autochthonous and humanised metastasis models), a metastatic tissue banking network with rapid autopsy, and a trial arm for 'anti-metastatic' agents tested in the adjuvant and molecular residual disease setting where they can plausibly work.","asOf":"2026-09-08","links":[{"label":"Cancer Grand Challenges","url":"https://cancergrandchallenges.org/"}],"tags":[],"related":["idea-ctdna-escalation-tnbc","idea-fund-brain-metastases-programme"],"cancers":["pancreatic","tnbc","melanoma","colorectal"],"sections":[],"technologies":["mrd-testing","pdx-models"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["mrd","ctdna","oligometastatic"],"trials":[],"people":["klaus-pantel"],"bottlenecks":["b-funding-allocation","b-metastasis-biology"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hypothesis":"Ring-fencing 10% of a national cancer research budget for metastasis for a decade at least triples the number of registered interventional trials with a metastasis-prevention primary endpoint and produces at least one approved agent labelled for prevention of metastatic relapse.","rationale":"Analyses of NCI portfolios have found metastasis-specific research at a few percent of spend despite its share of mortality; the Metastasis Research Society and the UK's Cancer Grand Challenges have argued that the field is starved of models and of trial designs that can show anti-metastatic effect. Ring-fencing worked to create fields in HIV cure research and in paediatric oncology through the Children's Oncology Group.","test":"Portfolio audit at baseline, then a funded pilot of 3 to 5 metastasis-prevention trials in high-risk resected disease (for example pancreatic, TNBC, melanoma) using ctDNA-defined populations; success is feasibility of accrual, endpoint acceptance by regulators, and a signal in at least one trial within six years.","maturity":"speculative","actor":"policy","cost":"large","horizonYears":8},"route":"/ideas/idea-fund-metastasis-moonshot/","neighbours":{"idea":[{"id":"idea-ctdna-escalation-tnbc","kind":"idea","name":"ctDNA-triggered escalation in early TNBC","route":"/ideas/idea-ctdna-escalation-tnbc/"},{"id":"idea-fund-ten-year-hard-problem-awards","kind":"idea","name":"Ten-year awards for scientists who commit to one hard problem","route":"/ideas/idea-fund-ten-year-hard-problem-awards/"},{"id":"idea-fund-brain-metastases-programme","kind":"idea","name":"Treat brain metastases as a disease with its own trials programme","route":"/ideas/idea-fund-brain-metastases-programme/"}],"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"},{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"technology":[{"id":"mrd-testing","kind":"technology","name":"MRD / molecular residual disease testing","route":"/technologies/mrd-testing/"},{"id":"pdx-models","kind":"technology","name":"Patient-derived xenografts","route":"/technologies/pdx-models/"}],"term":[{"id":"ctdna","kind":"term","name":"Circulating tumour DNA (ctDNA)","route":"/terms/ctdna/"},{"id":"mrd","kind":"term","name":"Minimal / molecular residual disease (MRD)","route":"/terms/mrd/"},{"id":"oligometastatic","kind":"term","name":"Oligometastatic disease","route":"/terms/oligometastatic/"}],"person":[{"id":"klaus-pantel","kind":"person","name":"Klaus Pantel","route":"/people/klaus-pantel/"}],"bottleneck":[{"id":"b-funding-allocation","kind":"bottleneck","name":"Funding follows fashion, not burden","route":"/bottlenecks/b-funding-allocation/"},{"id":"b-metastasis-biology","kind":"bottleneck","name":"Metastasis is understood least and studied last","route":"/bottlenecks/b-metastasis-biology/"}]}}